Study of TCP-ATRA for Adult Patients With AML and MDS

NCT02273102 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndromes
Leukemia

Interventions

DRUG: Tranylcypromine
DRUG: Tretinoin

Sponsor

University of Miami

Collaborators

[object Object]
[object Object]